Dexcom Inc

• Country

  United States of America

• Sector

  Health Care

• Industry group

  Health Care Equipment & Services

• Industry

  Health Care Equipment & Supplies

• Sub-sector

  Health Care

• Capitalization (millions of $)

  52484

• Ticker

  DXCM.O

• ISIN

  US2521311074

• IPO date

  2005-04-14

• Availability on Russian exchanges

  Yes

• Reporting for

  2024-02-08

• Date fact. publication of reports

  2023-12-31

Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.